Insufficient scRNA-seq data for expression of IGSF1 at single-cell level.
Insufficient scRNA-seq data for expression of IGSF1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 97% | 666.12 | 631 / 653 | 82% | 185.15 | 498 / 605 |
brain | 90% | 997.19 | 2366 / 2642 | 81% | 12.82 | 574 / 705 |
adrenal gland | 28% | 292.25 | 72 / 258 | 57% | 29.80 | 131 / 230 |
heart | 82% | 1026.81 | 704 / 861 | 0% | 0 | 0 / 0 |
esophagus | 62% | 289.16 | 894 / 1445 | 17% | 0.63 | 32 / 183 |
prostate | 62% | 205.29 | 152 / 245 | 10% | 0.37 | 51 / 502 |
breast | 37% | 151.63 | 171 / 459 | 28% | 10.67 | 310 / 1118 |
uterus | 38% | 123.41 | 64 / 170 | 19% | 1.89 | 85 / 459 |
blood vessel | 56% | 196.90 | 747 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 28% | 67.94 | 93 / 328 | 24% | 4.16 | 43 / 178 |
ovary | 27% | 80.85 | 49 / 180 | 19% | 1.14 | 82 / 430 |
intestine | 36% | 89.79 | 348 / 966 | 5% | 0.21 | 27 / 527 |
stomach | 30% | 136.86 | 106 / 359 | 5% | 0.22 | 14 / 286 |
liver | 7% | 14.94 | 15 / 226 | 27% | 3.21 | 111 / 406 |
bladder | 19% | 42.00 | 4 / 21 | 9% | 0.40 | 43 / 504 |
adipose | 21% | 56.74 | 249 / 1204 | 0% | 0 | 0 / 0 |
kidney | 12% | 23.44 | 11 / 89 | 8% | 0.42 | 74 / 901 |
lung | 1% | 3.29 | 5 / 578 | 14% | 0.76 | 162 / 1155 |
skin | 8% | 22.56 | 140 / 1809 | 4% | 0.46 | 21 / 472 |
muscle | 11% | 46.20 | 86 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.07 | 1 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.06 | 1 / 45 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
peripheral blood | 1% | 4.22 | 5 / 929 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.57 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0032926 | Biological process | negative regulation of activin receptor signaling pathway |
GO_0002764 | Biological process | immune response-regulating signaling pathway |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0038102 | Molecular function | activin receptor antagonist activity |
GO_0005515 | Molecular function | protein binding |
GO_0034711 | Molecular function | inhibin binding |
Gene name | IGSF1 |
Protein name | Immunoglobulin superfamily member 1 Immunoglobulin superfamily member 1 (IgSF1) (Immunoglobulin-like domain-containing protein 1) (Inhibin-binding protein) (InhBP) (Pituitary gland-specific factor 2) (p120) |
Synonyms | IGDC1 KIAA0364 PGSF2 |
Description | FUNCTION: Seems to be a coreceptor in inhibin signaling, but seems not to be a high-affinity inhibin receptor. Antagonizes activin A signaling in the presence or absence of inhibin B (By similarity). Necessary to mediate a specific antagonistic effect of inhibin B on activin-stimulated transcription. . |
Accessions | Q8N6C5 ENST00000650945.1 ENST00000370900.5 [Q8N6C5-3] ENST00000370901.4 [Q8N6C5-3] A0A494C0K8 ENST00000361420.8 [Q8N6C5-1] A0A494C0W8 ENST00000370910.5 [Q8N6C5-2] ENST00000651402.1 A0A494C0E7 A0A494C0H8 ENST00000650730.1 ENST00000370903.8 [Q8N6C5-4] ENST00000370904.6 [Q8N6C5-2] ENST00000651556.1 [Q8N6C5-1] ENST00000652189.1 |